During the past decade, UVRI-IAVI HIV Vaccine Program LTD. CRS conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UVRI-IAVI HIV Vaccine Program LTD. CRS" #1 collaborator was "Medical Research Council, South Africa" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UVRI-IAVI HIV Vaccine Program LTD. CRS" are "HIV Infections" (2 trials), "COVID-19" (1 trials) and "SARS-CoV-2 Infection" (1 trials). Many other conditions were trialed in "UVRI-IAVI HIV Vaccine Program LTD. CRS" in a lesser frequency.

Most popular intervention types in "UVRI-IAVI HIV Vaccine Program LTD. CRS" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CAB LA" (1 trials), "Moderna mRNA-1273" (1 trials), "Oral CAB" (1 trials), "Oral TDF/FTC" (1 trials) and "Placebo for CAB LA" (1 trials). Other intervention names were less common.

The vast majority of trials in "UVRI-IAVI HIV Vaccine Program LTD. CRS" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UVRI-IAVI HIV Vaccine Program LTD. CRS". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UVRI-IAVI HIV Vaccine Program LTD. CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UVRI-IAVI HIV Vaccine Program LTD. CRS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".